Tags

Type your tag names separated by a space and hit enter

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
MMWR Recomm Rep. 2008 Sep 19; 57(RR-8):1-20.MR

Abstract

Serologic testing for hepatitis B surface antigen (HBsAg) is the primary way to identify persons with chronic hepatitis B virus (HBV) infection. Testing has been recommended previously for pregnant women, infants born to HBsAg-positive mothers, household contacts and sex partners of HBV-infected persons, persons born in countries with HBsAg prevalence of >/=8%, persons who are the source of blood or body fluid exposures that might warrant postexposure prophylaxis (e.g., needlestick injury to a health-care worker or sexual assault), and persons infected with human immunodeficiency virus. This report updates and expands previous CDC guidelines for HBsAg testing and includes new recommendations for public health evaluation and management for chronically infected persons and their contacts. Routine testing for HBsAg now is recommended for additional populations with HBsAg prevalence of >/=2%: persons born in geographic regions with HBsAg prevalence of >/=2%, men who have sex with men, and injection-drug users. Implementation of these recommendations will require expertise and resources to integrate HBsAg screening in prevention and care settings serving populations recommended for HBsAg testing. This report is intended to serve as a resource for public health officials, organizations, and health-care professionals involved in the development, delivery, and evaluation of prevention and clinical services.

Authors+Show Affiliations

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road, MS G-37, Atlanta GA 30333, USA. chw4@cdc.govNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

18802412

Citation

Weinbaum, Cindy M., et al. "Recommendations for Identification and Public Health Management of Persons With Chronic Hepatitis B Virus Infection." MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, vol. 57, no. RR-8, 2008, pp. 1-20.
Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1-20.
Weinbaum, C. M., Williams, I., Mast, E. E., Wang, S. A., Finelli, L., Wasley, A., Neitzel, S. M., & Ward, J. W. (2008). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, 57(RR-8), 1-20.
Weinbaum CM, et al. Recommendations for Identification and Public Health Management of Persons With Chronic Hepatitis B Virus Infection. MMWR Recomm Rep. 2008 Sep 19;57(RR-8):1-20. PubMed PMID: 18802412.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. AU - Weinbaum,Cindy M, AU - Williams,Ian, AU - Mast,Eric E, AU - Wang,Susan A, AU - Finelli,Lyn, AU - Wasley,Annemarie, AU - Neitzel,Stephanie M, AU - Ward,John W, AU - ,, PY - 2008/9/20/pubmed PY - 2008/10/1/medline PY - 2008/9/20/entrez SP - 1 EP - 20 JF - MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports JO - MMWR Recomm Rep VL - 57 IS - RR-8 N2 - Serologic testing for hepatitis B surface antigen (HBsAg) is the primary way to identify persons with chronic hepatitis B virus (HBV) infection. Testing has been recommended previously for pregnant women, infants born to HBsAg-positive mothers, household contacts and sex partners of HBV-infected persons, persons born in countries with HBsAg prevalence of >/=8%, persons who are the source of blood or body fluid exposures that might warrant postexposure prophylaxis (e.g., needlestick injury to a health-care worker or sexual assault), and persons infected with human immunodeficiency virus. This report updates and expands previous CDC guidelines for HBsAg testing and includes new recommendations for public health evaluation and management for chronically infected persons and their contacts. Routine testing for HBsAg now is recommended for additional populations with HBsAg prevalence of >/=2%: persons born in geographic regions with HBsAg prevalence of >/=2%, men who have sex with men, and injection-drug users. Implementation of these recommendations will require expertise and resources to integrate HBsAg screening in prevention and care settings serving populations recommended for HBsAg testing. This report is intended to serve as a resource for public health officials, organizations, and health-care professionals involved in the development, delivery, and evaluation of prevention and clinical services. SN - 1545-8601 UR - https://www.unboundmedicine.com/medline/citation/18802412/full_citation L2 - https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5708a1.htm DB - PRIME DP - Unbound Medicine ER -